TERT occurs widely in a variety of malignant tumors, is related to the prognosis of patients,7 and is highly expressed in glioma tissues.8 In this study, the gene mutation of IDH1/2 and TERT promoter region was sequenced, and the postoperative follow-up was carried out. The gene discussed is TERT; the disease is central nervous system cancer.